Balancing risks and benefits: Primum non nocere is too simplistic.
Halsey
N A
NA
Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of PublicHealth, Baltimore, MD 21205, USA. nhalsey@jhsph.edu
Goldman
L
L
D002487:Centers for Disease Control and Prevention, U.S. / Q000592:standards; D005260:Female; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000627:therapeutic use*; D006625:Hippocratic Oath; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007231:Infant, Newborn / Q000276:immunology*; D008630:Mercury Poisoning / Q000453:epidemiology; D016134:Organizational Policy; D010372:Pediatrics / Q000592:standards; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D018570:Risk Assessment; D012955:Societies, Medical / Q000592:standards; D013849:Thimerosal / Q000009:adverse effects*; D014481:United States / Q000453:epidemiology
D017325:Hepatitis B Vaccines; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal